| Year |
Citation |
Score |
| 2018 |
Robeson AC, Lindblom KR, Wojton J, Kornbluth S, Matsuura K. Dimer-specific immunoprecipitation of active caspase-2 identifies TRAF proteins as novel activators. The Embo Journal. PMID 29875129 DOI: 10.15252/Embj.201797072 |
0.758 |
|
| 2017 |
Jaime-Ramirez AC, Dmitrieva N, Yoo JY, Banasavadi-Siddegowda Y, Zhang J, Relation T, Bolyard-Blessing C, Wojton J, Kaur B. Humanized Chondroitinase ABC Sensitizes Glioblastoma Cells to Temozolomide. The Journal of Gene Medicine. PMID 28087981 DOI: 10.1002/Jgm.2942 |
0.8 |
|
| 2016 |
Bolyard CM, Meisen WH, Banasavadi-Siddegowda Y, Hardcastle J, Yoo JY, Wohleb ES, Wojton J, Yu JG, Dubin S, Khosla M, Xu B, Smith JG, Alvarez-Breckenridge C, Pow-Anpongkul P, Pichiorri F, et al. BAI1 Orchestrates Macrophage Inflammatory Response to HSV Infection- implications for Oncolytic Viral Therapy. Clinical Cancer Research : An Official Journal of the American Association For Cancer Research. PMID 27852701 DOI: 10.1158/1078-0432.Ccr-16-1818 |
0.709 |
|
| 2016 |
Yoo JY, Jaime-Ramirez AC, Bolyard C, Dai H, Nallanagulagari T, Wojton J, Hurwitz B, Relation T, Yu JG, Lee TJ, Lotze MT, Zhang J, Croce CM, Yu J, Caligiuri MA, et al. Bortezomib treatment sensitizes oncolytic HSV-1 treated tumors to NK cell immunotherapy. Clinical Cancer Research : An Official Journal of the American Association For Cancer Research. PMID 27390350 DOI: 10.1158/1078-0432.Ccr-16-1003 |
0.81 |
|
| 2015 |
Wojton J, Meisen WH, Kaur B. How to train glioma cells to die: molecular challenges in cell death. Journal of Neuro-Oncology. PMID 26542029 DOI: 10.1007/S11060-015-1980-1 |
0.812 |
|
| 2014 |
Huang B, Yang CS, Wojton J, Huang NJ, Chen C, Soderblom EJ, Zhang L, Kornbluth S. Metabolic control of Ca2+/calmodulin-dependent protein kinase II (CaMKII)-mediated caspase-2 suppression by the B55β/protein phosphatase 2A (PP2A). The Journal of Biological Chemistry. 289: 35882-90. PMID 25378403 DOI: 10.1074/Jbc.M114.585844 |
0.721 |
|
| 2014 |
Wojton J, Meisen WH, Jacob NK, Thorne AH, Hardcastle J, Denton N, Chu Z, Dmitrieva N, Marsh R, Van Meir EG, Kwon CH, Chakravarti A, Qi X, Kaur B. SapC-DOPS-induced lysosomal cell death synergizes with TMZ in glioblastoma. Oncotarget. 5: 9703-9. PMID 25210852 DOI: 10.18632/Oncotarget.2232 |
0.771 |
|
| 2014 |
Van Brocklyn JR, Wojton J, Meisen WH, Kellough DA, Ecsedy JA, Kaur B, Lehman NL. Aurora-A inhibition offers a novel therapy effective against intracranial glioblastoma. Cancer Research. 74: 5364-70. PMID 25106428 DOI: 10.1158/0008-5472.Can-14-0386 |
0.828 |
|
| 2014 |
Wojton J, Elder J, Kaur B. How efficient are autophagy inhibitors as treatment for glioblastoma? Cns Oncology. 3: 5-7. PMID 25054892 DOI: 10.2217/Cns.13.52 |
0.819 |
|
| 2014 |
Yan F, Alinari L, Lustberg ME, Martin LK, Cordero-Nieves HM, Banasavadi-Siddegowda Y, Virk S, Barnholtz-Sloan J, Bell EH, Wojton J, Jacob NK, Chakravarti A, Nowicki MO, Wu X, Lapalombella R, et al. Genetic validation of the protein arginine methyltransferase PRMT5 as a candidate therapeutic target in glioblastoma. Cancer Research. 74: 1752-65. PMID 24453002 DOI: 10.1158/0008-5472.Can-13-0884 |
0.785 |
|
| 2014 |
Kaur B, Meisen WH, Hardcastle J, Wojton J, Wohleb E, Alvarez-Breckenridge C, Pow-anpongkul P, Godbout J. Vstat120 Reduces The Innate Inflammatory Response To Infection And Enhances Oncolytic Viral Therapy For Glioblastoma. Neuro-Oncology. 16. DOI: 10.1093/Neuonc/Nou209.2 |
0.813 |
|
| 2013 |
Wojton J, Chu Z, Mathsyaraja H, Meisen WH, Denton N, Kwon CH, Chow LM, Palascak M, Franco R, Bourdeau T, Thornton S, Ostrowski MC, Kaur B, Qi X. Systemic delivery of SapC-DOPS has antiangiogenic and antitumor effects against glioblastoma. Molecular Therapy : the Journal of the American Society of Gene Therapy. 21: 1517-25. PMID 23732993 DOI: 10.1038/Mt.2013.114 |
0.81 |
|
| 2013 |
Wojton J, Jacob NK, Denton N, Dmitrieva N, Nakashima H, Kwon C, Chow L, Chiocca EA, Chakravarti A, Kaur B, Qi X. Abstract 2169: SapC-DOPS induces lethal mitophagy in glioblastoma. Cancer Research. 73: 2169-2169. DOI: 10.1158/1538-7445.Am2013-2169 |
0.808 |
|
| 2012 |
Alvarez-Breckenridge CA, Yu J, Price R, Wojton J, Pradarelli J, Mao H, Wei M, Wang Y, He S, Hardcastle J, Fernandez SA, Kaur B, Lawler SE, Vivier E, Mandelboim O, et al. NK cells impede glioblastoma virotherapy through NKp30 and NKp46 natural cytotoxicity receptors. Nature Medicine. 18: 1827-34. PMID 23178246 DOI: 10.1038/Nm.3013 |
0.773 |
|
| 2012 |
Yoo JY, Pradarelli J, Haseley A, Wojton J, Kaka A, Bratasz A, Alvarez-Breckenridge CA, Yu JG, Powell K, Mazar AP, Teknos TN, Chiocca EA, Glorioso JC, Old M, Kaur B. Copper chelation enhances antitumor efficacy and systemic delivery of oncolytic HSV. Clinical Cancer Research : An Official Journal of the American Association For Cancer Research. 18: 4931-41. PMID 22753591 DOI: 10.1158/1078-0432.Ccr-12-0697 |
0.758 |
|
| 2012 |
Haseley A, Boone S, Wojton J, Yu L, Yoo JY, Yu J, Kurozumi K, Glorioso JC, Caligiuri MA, Kaur B. Extracellular matrix protein CCN1 limits oncolytic efficacy in glioma. Cancer Research. 72: 1353-62. PMID 22282654 DOI: 10.1158/0008-5472.Can-11-2526 |
0.771 |
|
| 2012 |
Yang FH, Zhang B, Zhou DJ, Bie L, Tom MW, Drummond DC, Nicolaides T, Mueller S, Banerjee A, Park JW, Prados MD, James DC, Gupta N, Hashizume R, Strohbehn GW, ... ... Wojton J, ... ... Wojton JA, et al. LAB-EXPERIMENTAL (PRE-CLINICAL) THERAPEUTICS AND PHARMACOLOGY Neuro-Oncology. 14: vi25-vi37. DOI: 10.1093/Neuonc/Nos222 |
0.748 |
|
| 2010 |
Wojton J, Kaur B. Impact of tumor microenvironment on oncolytic viral therapy. Cytokine & Growth Factor Reviews. 21: 127-34. PMID 20399700 DOI: 10.1016/J.Cytogfr.2010.02.014 |
0.818 |
|
| Show low-probability matches. |